BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.
- Company
- Beckman Coulter, Inc.
- Recall Initiated
- November 18, 2022
- Posted
- January 3, 2023
- Recall Number
- Z-0777-2023
- Quantity
- 3657 units
- Firm Location
- Miami, FL
Reason for Recall
Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212
Distribution
US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan
Lot / Code Info
UDI/DI 10837461002611, Lot 565-21: 11-30-2022
Root Cause
Under Investigation by firm
Action Taken
The firm issued a MEDICAL DEVICE RECALL notice to its consignees on 11/18/2022 by mail and email. The notice explained the problem and requested the following actions be taken: "If IRISpec CB controls pass (QC results are within QC acceptance criteria): Continue to process patient samples per IFU (P/N 301-7146BE) If IRISpec CB controls fail (QC results are outside QC acceptance criteria): Refer to Addendum A below for troubleshooting No retrospective review of QC or patient sample results is necessary." "Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter."